Simon Latimer | Head of IR |
John Higgins | CEO |
Matthew Korenberg | CFO |
Matt Foehr | COO |
Lawrence Solow | CJS Securities |
Matt Hewitt | Craig Hallum Capital Group |
Jacob Johnson | Stephens |
Scott Henry | ROTH Capital |
Good day and thank you for standing by. Welcome to the Ligand Pharmaceuticals Third Quarter Earnings Call. At this time all participants are in a listen-only mode. After the speaker's presentation there will be a question and answer session. [Operator Instructions.] I'd now like to hand the conference over to your first speaker for today, Mr.